We estimated glycated ("glycosylated") hemoglobin in erythrocytes of hemodialyzed uremic patients by the aminophenylboronic acid affiriity-chromatographic method and by an ion-exchange chromatographic method. As expected, apparent HbA1 concentrations were above normal in the uremic patients, owing to interference by the carbamylated hemoglobin. However, there was no significant difference between values for uremic and normal subjects when glycated hemoglobin was measured by the affinity method. Evidently it is unaffected by the presence of hemoglobin species modified by reactants not displaying a cis-1 ,2-diol group, such as carbamylated hemoglobin. For this reason it is preferable to the ion-exchange chromatographic method for accurate measurement of glycated hemoglobin.
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Concentrations of hemoglobin A1 (HbA1) reportedly are increased, both in diabetic patients and in patients with renal failure, when measured by ion-exchange chromatography (1,2). However, when measured by the thiobarbituric acid method, a chemical method specific for the detection of glycation, patients with renal failure showed values for glycated hemoglobin similar to those observed in normal subjects, suggesting that the high values in these patients are a result of binding of something other than glucose to hemoglobin (2). Aminophenylboronic acid affinity chromatography, a simple method recently developed for measurement of glycated hemoglobin, is said to be more specific than ion-exchange chromatography and also more effective in distinguishing diabetic patients from normal subjects (4, 5). The method is based on the interaction of immobilized m-aminophenylboronic acid with the cis-1,2-diol group of the glucose residue attached to the hemoglobin molecule. Thus it should not be affected by hemoglobin that has been modified by reactants not displaying a cis-1,2-diol group, such as carbamylated hemoglobin. We sought to confirm that values for glycated hemoglobin in uremic patients with no history of diabetes are within the normal range when measured by affinity chromatography, thus further establishing that hemoglobin species modified by other reactants than glucose do not interfere.
Materials and Methods

Blood specimens:
Whole blood, anticoagulated with EDTA, was obtained from two groups of subjects. The first group consisted of 28 normal subjects (13 women and 15
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Results and Discussion
As expected, the mean percentage of apparent HbA1 in the uremic patients by ion-exchange chromatography (8.17%, SD 0.86%) significantly exceeded that in the normal subjects (6.31%, SD 0.55%; p < 0.001, Student's t-test) (Figure 1) . It approximated the value found by Fluckiger et al. (3) . On the other hand, results by affinity chromatography for the uremic patients (7.10%, SD 0.99%) did not differ significantly from those for the normal subjects (7.25%, SD 0.54%). Evidently carbamylated hemoglobin, which is present in higher concentration in the blood of uremic patients, does not interfere with measurement of glycated hemoglobin by the affinity method. The variance between these two groups was, however, significantly different (p < 0.01, Ftest). When we established a normal range (mean ± 2 SD) by using the affinity data from the normal group (6.2-8. In keeping with our finding, the affinity method has also been shown to be free from many other interferences that affect the ion-exchange chromatographic method. The pres- We conclude that all hemoglobin species modified by other reactants than glucose and not displaying a cis-1,2-diol group should not interfere with measurement of glycatedhemoglobin by the phenylboronate affinity method.
